Jackson Laboratory Cancer Center scientists are combining human cancer genomics with mouse biology and genetics expertise to interrogate cancer in clinically meaningful ways.
JAX Professors Roel Verhaak and Ching Lau are leading research programs into glioblastoma with awards from the National Cancer Institute as part of a large national research consortium.
Armed with new funding from the V Foundation, Olga Anczuków-Camarda is uncovering genetic changes in the breast, paving the road to early cancer detection and prevention.
Chia-lin Wei is at the center of a critical knowledge hub for advanced sequencing technologies at the center of JAX’s research program.
Paper provides important insight for B-cell lymphomagenesis from mouse models to human disease.
Recently developed outbred mouse populations, such as the diversity outbred (DO) mice at The Jackson Laboratory (JAX), have created research options that parallel or even exceed human genetic diversity. Research with DO mice offers a full range of genetic diversity, and therefore more generalizability of responses across populations.
JAX researchers have developed a new computational algorithm that is capable of modeling the effects of both stochastic gene expression and cell-to-cell variability in a cell population.
Using computer models, researchers have identified a potential new therapy that would reduce the long-term side effects of radiation therapy in pediatric brain cancer patients.
Clinicians, translational researchers, academics, clinical lab personnel, and even patients may choose between three levels of access to best suit their needs.